(Q43541762)

24 November 2017

title

ERCC1 and XRCC1 gene polymorphisms predict response to neoadjuvant radiochemotherapy in esophageal cancer (English)

1 reference

24 November 2017

0 references

1

Ute Warnecke-Eberz

1 reference

24 November 2017

Elfriede Bollschweiler

6

object named as

Elfriede Bollschweiler

1 reference

24 November 2017

10

Ralf Metzger

1 reference

24 November 2017

9

Arnulf H Hölscher

1 reference

24 November 2017

Daniel Vallböhmer

2

1 reference

24 November 2017

Hakan Alakus

3

1 reference

24 November 2017

Fabian Kütting

4

1 reference

24 November 2017

Georg Lurje

5

1 reference

24 November 2017

Anke Wienand-Dorweiler

7

1 reference

24 November 2017

Uta Drebber

8

1 reference

24 November 2017

publication date

7 May 2009

1 reference

Journal of Gastrointestinal Surgery

24 November 2017

published in

1 reference

24 November 2017

volume

13

1 reference

24 November 2017

issue

8

1 reference

24 November 2017

page(s)

1411-1421

1 reference

https://scigraph.springernature.com/pub.10.1007/s11605-009-0881-z

24 November 2017

exact match

0 references

cites work

Integration of HapMap-based SNP pattern analysis and gene expression profiling reveals common SNP profiles for cancer therapy outcome predictor genes.

1 reference

https://api.crossref.org/works/10.1007%2FS11605-009-0881-Z

[Regression of oesophageal carcinomas after neoadjuvant radiochemotherapy: criteria of the histopathological evaluation].

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-009-0881-Z

Association between excision repair cross-complementation group 1 polymorphism and clinical outcome of platinum-based chemotherapy in patients with epithelial ovarian cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-009-0881-Z

Expression of genes related to activity of oxaliplatin and 5-fluorouracil in endoscopic biopsies of primary esophageal cancer in patients receiving oxaliplatin, 5-flourouracil and radiation: characterization and exploratory analysis with survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11605-009-0881-Z

Locally advanced esophageal cancer

21 January 2018

1 reference

12 December 2020

Histomorphologic tumor regression and lymph node metastases determine prognosis following neoadjuvant radiochemotherapy for esophageal cancer: implications for response classification

1 reference

12 December 2020

ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy

1 reference

12 December 2020

Genome-wide loss of heterozygosity and copy number alteration in esophageal squamous cell carcinoma using the Affymetrix GeneChip Mapping 10 K array

1 reference

12 December 2020

Polymorphisms in DNA repair genes and associations with cancer risk

1 reference

12 December 2020

Esophageal cancer: CT, endoscopic US, and FDG PET for assessment of response to neoadjuvant therapy--systematic review

1 reference

12 December 2020

Preoperative chemoradiotherapy for oesophageal cancer: a systematic review and meta-analysis

1 reference

12 December 2020

Platinum-DNA adduct, nucleotide excision repair and platinum based anti-cancer chemotherapy.

1 reference

12 December 2020

Determinants of chemosensitivity in gastric cancer

1 reference

12 December 2020

Benefits and limitations of Kaplan-Meier calculations of survival chance in cancer surgery

1 reference

12 December 2020

A haplotype of the methylenetetrahydrofolate reductase gene predicts poor tumor response in rectal cancer patients receiving preoperative chemoradiation

1 reference

12 December 2020

Current status of excision repair cross complementing-group 1 (ERCC1) in cancer.

1 reference

12 December 2020

ERCC1 RNA expression in peripheral blood predicts minor histopathological response to neoadjuvant radio-chemotherapy in patients with locally advanced cancer of the esophagus.

1 reference

12 December 2020

Cancer pharmacogenetics: polymorphisms, pathways and beyond

1 reference

12 December 2020

A meta-analysis of randomized controlled trials that compared neoadjuvant chemoradiation and surgery to surgery alone for resectable esophageal cancer

1 reference

12 December 2020

Genetic variations in radiation and chemotherapy drug action pathways predict clinical outcomes in esophageal cancer

1 reference

12 December 2020

High specificity of quantitative excision repair cross-complementing 1 messenger RNA expression for prediction of minor histopathological response to neoadjuvant radiochemotherapy in esophageal cancer

1 reference

12 December 2020

Genome-wide detection of allelic imbalance using human SNPs and high-density DNA arrays

1 reference

12 December 2020

Prediction of response to chemotherapy by ERCC1 immunohistochemistry and ERCC1 polymorphism in ovarian cancer

1 reference

12 December 2020

ERCC1 codon 118 polymorphism is a predictive factor for the tumor response to oxaliplatin/5-fluorouracil combination chemotherapy in patients with advanced colorectal cancer.

1 reference

12 December 2020

Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis.

1 reference

12 December 2020

Polymorphisms of the DNA repair genes XRCC1 and XRCC3 and risk of lung and colorectal cancer: a case-control study in a Southern Italian population.

1 reference

12 December 2020

Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy.

1 reference

12 December 2020

Genetic polymorphisms and head and neck cancer risk (Review).

1 reference

12 December 2020

Tumour regression in non-small-cell lung cancer following neoadjuvant therapy. Histological assessment

1 reference

12 December 2020

Human DNA repair genes

1 reference

12 December 2020

Assessment of infusional 5-fluorouracil schedule and dose intensity: a Southwest Oncology Group and Eastern Cooperative Oncology Group study

1 reference

12 December 2020

Survival after surgery for oesophageal cancer: a population-based study.

1 reference

12 December 2020

Patients with ERCC1-negative locally advanced esophageal cancers may benefit from preoperative chemoradiotherapy.

1 reference

12 December 2020

XRCC1 R399Q polymorphism is associated with response to platinum-based neoadjuvant chemotherapy in bulky cervical cancer

1 reference

12 December 2020

[Polymorphisms of thymidylate synthase gene and correlation of its protein expression to lymph node metastasis of esophageal squamous cell carcinoma]

1 reference

12 December 2020

Prognostic significance of the polymorphisms in thymidylate synthase and methylenetetrahydrofolate reductase gene in lung cancer.

1 reference

12 December 2020

Neoadjuvant treatment for resectable cancer of the esophagus and the gastroesophageal junction: a meta-analysis of randomized clinical trials

1 reference

12 December 2020

XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy

1 reference

12 December 2020

Polymorphisms in Genes of Nucleotide and Base Excision Repair: Risk and Prognosis of Colorectal Cancer

1 reference

12 December 2020

Genetic polymorphisms and treatment response in advanced non-small cell lung cancer.

1 reference

12 December 2020

Biochemical analysis of the damage recognition process in nucleotide excision repair

1 reference

12 December 2020

A multivariate analysis of genomic polymorphisms: prediction of clinical outcome to 5-FU/oxaliplatin combination chemotherapy in refractory colorectal cancer

1 reference

12 December 2020

Relationships between promoter polymorphisms in the thymidylate synthase gene and mRNA levels in colorectal cancers

1 reference

12 December 2020

The erbB2/HER2/neu receptor polymorphism Ile655Val and breast cancer risk

1 reference

12 December 2020

Pharmacogenetic prediction of clinical outcome in advanced colorectal cancer patients receiving oxaliplatin/5-fluorouracil as first-line chemotherapy

1 reference

12 December 2020

Excision repair cross complementing-group 1: gene expression and platinum resistance.

1 reference

12 December 2020

Genomic profiling associated with recurrence in patients with rectal cancer treated with chemoradiation.

1 reference

12 December 2020

Identification of single nucleotide polymorphisms in human DNA repair genes

1 reference

12 December 2020

Single nucleotide polymorphism in the 5' tandem repeat sequences of thymidylate synthase gene predicts for response to fluorouracil-based chemotherapy in advanced colorectal cancer patients

1 reference

12 December 2020

Survival plots of time-to-event outcomes in clinical trials: good practice and pitfalls

1 reference

12 December 2020

Cancer statistics, 2007

1 reference

12 December 2020

10.1007/S11605-009-0881-Z

Identifiers

DOI

1 reference

24 November 2017

1 reference